Nashwa Ahmad Mohammed Amin
Asst. Professor
Incidence of pulmonary hypertension in COPD and its relation to inflammatory marker interleukin-1
• 2024
Publication Information
Authors
Sherif Ahmed Eissa1, Youssef Mohamed Amin Soliman2, Tarek Samy Essawy1,
Mostafa Mohammed Abdelrahman Elsayed1 and Nashwa Ahmed Amin1*
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background Many COPD patients present with severe PH defined by a pulmonary vascular resistance (PVR) > 5 WU
as measured by right heart catheterization (RHC), and inflammation is thought to be contributing strongly to pulmo
nary vascular remodeling in COPD besides hypoxia. Interleukin-1 (IL-1) is thought to be a major cytokine that may be
involved in development of PH in these patients.
Objective This study aimed to identify the incidence of PH in COPD and its relation to inflammatory marker IL-1.
Patients and methods One-hundred COPD patients underwent echocardiography and serum IL-1 analysis,
and patients with high probability of PH underwent pulmonary artery catheterization using Swan-Ganz catheter.
Results The mean serum IL-1 level was 82 pg/ml ± 22 pg/ml (the normal IL-1 serum level is known to be 0:5 pg/mL),
51% of the participants were categorized as having a low probability of PH, 35% was intermediate, and 14% was high.
RHC results were as follows: mild combined pre- and postcapillary PH was diagnosed in 14.3% of the patients. Mild
precapillary PH was found in 42.9%, making it the most common type. Severe combined pre- and postcapillary PH
was noted in 21.4% of the patients. Severe precapillary PH was present in 14.3%. A significant positive correlations
were observed between serum IL-1 and tricuspid regurgitation velocity (TRV) (r = 0.409, P < 0.001), estimated sys
tolic pulmonary artery pressure (ESPAP) (r = 0.508, P < 0.001), and mean pulmonary artery pressure (mPAP) (r = 0.410,
P = 0.140).
Conclusion Serum IL-1 is a potent predictor of a high probability of PH in COPD patients, and there was signifi
cant positive correlation between serum IL-1 and echocardiographic findings and PH probability and RHC findings
in COPD patients
as measured by right heart catheterization (RHC), and inflammation is thought to be contributing strongly to pulmo
nary vascular remodeling in COPD besides hypoxia. Interleukin-1 (IL-1) is thought to be a major cytokine that may be
involved in development of PH in these patients.
Objective This study aimed to identify the incidence of PH in COPD and its relation to inflammatory marker IL-1.
Patients and methods One-hundred COPD patients underwent echocardiography and serum IL-1 analysis,
and patients with high probability of PH underwent pulmonary artery catheterization using Swan-Ganz catheter.
Results The mean serum IL-1 level was 82 pg/ml ± 22 pg/ml (the normal IL-1 serum level is known to be 0:5 pg/mL),
51% of the participants were categorized as having a low probability of PH, 35% was intermediate, and 14% was high.
RHC results were as follows: mild combined pre- and postcapillary PH was diagnosed in 14.3% of the patients. Mild
precapillary PH was found in 42.9%, making it the most common type. Severe combined pre- and postcapillary PH
was noted in 21.4% of the patients. Severe precapillary PH was present in 14.3%. A significant positive correlations
were observed between serum IL-1 and tricuspid regurgitation velocity (TRV) (r = 0.409, P < 0.001), estimated sys
tolic pulmonary artery pressure (ESPAP) (r = 0.508, P < 0.001), and mean pulmonary artery pressure (mPAP) (r = 0.410,
P = 0.140).
Conclusion Serum IL-1 is a potent predictor of a high probability of PH in COPD patients, and there was signifi
cant positive correlation between serum IL-1 and echocardiographic findings and PH probability and RHC findings
in COPD patients